Rémi Lancar

Inserm — France

Immunology and Microbiology · Life Sciences

17h-index2.1kcitations44works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(10), Lymphoma Diagnosis and Treatment(10), Viral-associated cancers and disorders(10), HIV/AIDS drug development and treatment(9), Chronic Lymphocytic Leukemia Research(8)

Publications44 total

Immune reconstitution and evolution of B-cell–stimulating cytokines after R-CHOP therapy for HIV-associated DLBCL
Blood Advances·2024· 4 citedOpen Access
Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma
Cancers·2021· 5 citedOpen Access
Prospective evaluation of blood Epstein–Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas
AIDS·2021· 12 citedOpen Access
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection
Annals of Internal Medicine·2020
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection
Annals of Internal Medicine·2020· 11 cited
Risk Factors for Seborrhoeic Dermatitis Flares: Case-control and Case-crossover Study
Acta Dermato Venereologica·2020· 17 citedOpen Access
Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV
AIDS·2019· 11 cited
<i>In situ</i> BCL2 expression is an independent prognostic factor in HIV‐associated DLBCL, a LYMPHOVIR cohort study
British Journal of Haematology·2019· 11 citedOpen Access
Epstein–Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era
AIDS·2019· 15 cited
Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing
AIDS·2018· 1 cited
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era
AIDS·2017· 79 cited
High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort
Clinical Infectious Diseases·2015· 64 citedOpen Access
Characteristics and Outcome of HIV Associated Classical Hodgkin's Lymphoma Among 68 Patients Included in the French ANRS CO16 Lymphovir Cohort Study
Blood·2014· 5 cited
Facteurs de risque de dermatite séborrhéique : étude cas-témoins et cas-croisé. Étude EPIDERMAS
Annales de Dermatologie et de Vénéréologie·2014
Bleeding complications in primary percutaneous coronary intervention of ST‐elevation myocardial infarction in a radial center
Catheterization and Cardiovascular Interventions·2011· 25 cited
Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy
PLoS ONE·2011· 69 citedOpen Access
Alpha interferon administration during structured interruptions of combination antiretroviral therapy in patients with chronic HIV-1 infection: INTERVAC ANRS 105 trial
AIDS·2010· 32 cited
Diagnostic value of D-dimer in patients with suspected pulmonary embolism: Results from a multicentre outcome study
Thrombosis Research·2006· 43 cited
Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's Lymphoma
Journal of Clinical Oncology·2006· 196 citedOpen Access
Development and Validation of an Immunoassay for Identification of Recent Human Immunodeficiency Virus Type 1 Infections and Its Use on Dried Serum Spots
Journal of Clinical Microbiology·2005· 109 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Dominique Costagliola(22), Caroline Besson(9), Yassine Taoufik(9), Michèle Algarté-Génin(8), Houria Hendel-Chavez(8), Fabrice Bonnet(7), Sophie Prévôt(7), Nicolas Mounier(7), Marie‐Caroline Meyohas(6), Marialuisa Partisani(6), François Boué(5), Jean Gabarre(5), A. Kramar(5), Cécile Goujard(5), Régis Costello(5), Philippe Lambin(4), Pierre Scalliet(4), J. Bouzy(4), B. Marchou(4), Christian Funck‐Brentano(4)